Study Suggests Viagra May Help Prevent Cancer Metastasis by Disrupting Cholesterol Use
A recent study from the Weizmann Institute of Science suggests that sildenafil, the active ingredient in Viagra, may have the potential to prevent cancer from spreading. The research indicates that sildenafil interferes with cancer cells' ability to utilize cholesterol, which is crucial for their proliferation and metastasis. The study, published in Cancer Research, found that sildenafil blocks the enzyme phosphodiesterase type 5 (PDE5), leading to increased levels of cGMP, a signaling molecule. This molecule binds to a protein responsible for cholesterol transport within cells, thereby limiting the cholesterol available to cancer cells. The findings are based on experiments with mouse models, human cancer cell cultures, and an analysis of 20 years of health data from Clalit, an Israeli health provider. The study also noted that the combination of sildenafil with statins, which lower cholesterol production, showed an enhanced effect in preventing metastasis. 
